Clinical Trial Update: HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document reports results for a phase 1/2 trial evaluating HDR brachytherapy plus external beam radiotherapy and STAD for recurrent prostate cancer. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Loyola University | Conditions: Prostate Cancer - Recurrent | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-01-29